Sinai Center for Thrombosis Research

Baltimore, Maryland 21215

0 studies enrolling now · 14 studies all time

What they study most

Acute Coronary Syndrome, Aortic Surgery or Redo Surgery, COVID-19, Cardiovascular Disease, Cardiovascular Diseases, Coagulation, Coronary Artery Bypass Grafting, Coronary Artery Disease, Heart Failure, Myocardial Infarction, On-pump Double or Triple Valve Procedures, Open Heart Surgery

Studies at this site

• Assessment of Platelet Function in Patients Undergoing Open Heart Surgery — Status unconfirmed
• Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study — Stopped early
• The Evaluation of Hemostasis in Hospitalized COVID-19 Patients — Status unconfirmed
• The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease — Completed
• Influence of Edoxaban on Coagulability and Thrombin Generation: An in Vitro Study Focusing on Thrombelastography — Status unconfirmed
• Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor — Status unconfirmed
• Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty — Completed
• Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI) — Stopped early
• Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI — Status unconfirmed
• Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis — Status unconfirmed
• RapidTEG MA Validation — Stopped early
• A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540 — Completed